NCT04160611 is a Phase 3 clinical trial of Midazolam 7.5mg in In Vitro Fertilization, sponsored by University Hospital Sestre Milosrdnice.

Who is sponsoring NCT04160611?

NCT04160611 is sponsored by University Hospital Sestre Milosrdnice.

What drugs are being tested in NCT04160611?

Interventions in NCT04160611: Midazolam 7.5mg.

What condition does NCT04160611 study?

NCT04160611 studies In Vitro Fertilization, Stress, Midazolam Adverse Reaction, Stress, Emotional.

Is NCT04160611 still recruiting?

NCT04160611 is currently status unknown. Last updated 13 November 2019.

Last reviewed 2019-11-13 · How we verify

NCT04160611

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

What Amount of Stress is Enough for a Successful Conception?

Status unknown Phase 3 Last updated 13 November 2019

What this trial tests

Phase 3 trial testing Midazolam 7.5mg in In Vitro Fertilization in 40 participants. Status unknown.

Timeline

1 September 2019

Primary endpoint
30 June 2020

1 October 2020

Quick facts

Lead sponsor	University Hospital Sestre Milosrdnice
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 September 2019
Primary completion	30 June 2020
Estimated completion	1 October 2020
Sites	1 location across Croatia

Drugs / interventions tested

Midazolam 7.5mg — full drug profile →

Conditions studied

In Vitro Fertilization — all drugs for In Vitro Fertilization →
Stress — all drugs for Stress →
Midazolam Adverse Reaction — all drugs for Midazolam Adverse Reaction →
Stress, Emotional — all drugs for Stress, Emotional →

Sponsor

University Hospital Sestre Milosrdnice

Who can join

18 and older, female only, with In Vitro Fertilization or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to determine whether premedication with midazolam before oocyte aspiration in IVF procedures affects the amount of (oxidative) stress in women undergoing IVF and whether stress is also transmitted to the follicular fluid of aspirated follicles. The primary endpoint is the impact of stress during aspiration on the success of medically assisted fertilization (IVF / ICSI in the stimulated cycle).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for In Vitro Fertilization

Currently open trials in the same condition.

NCT07500337 — Day-4 Embryo Defragmentation: Blastocyst Rate and clInical Outcomes · NA · recruiting
NCT06766604 — Effect of Super-GDF9 on CAPA-IVM of COCs From Small Antral Follicles · NA · recruiting
NCT06261671 — Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates. · NA · recruiting
NCT06521957 — Effectiveness of CBT in Improving Psycho-Neuro-Endocrine Factors in Women Following In Vitro Fertilization Program · NA · recruiting
NCT06670586 — Assessment of Reproductive Outcomes in Non-Male Factor Infertility Patients: Conventional in Vitro Fertilisation Versus · NA · active not recruiting

Other University Hospital Sestre Milosrdnice trials

Trials by the same sponsor.

NCT07127848 — Investingation on Outcomes After Combining Septoplasty With Additional Procedures. · NA · enrolling by invitation
NCT06384469 — The Impact of Rhinoplasty Approach and Used Autologous Cartilage Grafts on the Nasal Skin-soft Tissue Envelope Metabolis · not yet recruiting
NCT05840406 — Effect of a Transversus Abdominis Plane Block on Wound Healing, Stress, and Immune Response After a Cesarean Delivery · NA · completed
NCT06243536 — The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients · Phase 4 · unknown
NCT05938985 — Croatian Version of the Ocular Surface Disease Index Questionnaire (OSDI) · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04160611 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Sestre Milosrdnice
Last refreshed: 13 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04160611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing